Table 2.

Safety Summary

Serious adverse events, No.	0
Unanticipated adverse events, No.	0
Study procedure‐related adverse events, No.	0
Nonserious adverse events (NSAEs), No.	54
Related/possibly related, No. (%)	32 (59)
Mild, No. (%)	27 (85)
Moderate, No. (%)	5 (15)
Severe, No. (%)	0
Patients with related/possibly related, cutaneous NSAEs, No.	14
Patients with related/possibly related, cutaneous NSAEs, No.	8
Asthma attack	1
Abdominal cramping	1
Constipation	2
Nausea	2
Chest pain (noncardiac)	1
Bitter taste	1